These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 2192625)

  • 1. Modeling inhibitors in the active site of aspartate aminotransferase.
    Taylor JE; Metzler DE; Arnone A
    Ann N Y Acad Sci; 1990; 585():58-67. PubMed ID: 2192625
    [No Abstract]   [Full Text] [Related]  

  • 2. INTERACTION OF ASPARTATE AMINOTRANSFERASE WITH AMINO ACIDS.
    SCOTTO P; SCARDI V
    Biochem J; 1965 Jun; 95(3):657-60. PubMed ID: 14342499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluorinated amino acids and phosphopyridoxyl fluoramino acids as reversible active site directed inhibitors of aspartate transaminase-1.
    Relimpio A; Slebe JC; Martinez-Carrion M
    Biochem Biophys Res Commun; 1975 Apr; 63(3):625-34. PubMed ID: 236745
    [No Abstract]   [Full Text] [Related]  

  • 4. Irreversible inactivation of aspartate aminotransferases during transamination with L-propargylglycine.
    Tanase S; Morino Y
    Biochem Biophys Res Commun; 1976 Feb; 68(4):1301-8. PubMed ID: 944577
    [No Abstract]   [Full Text] [Related]  

  • 5. Mitochondrial glutamate aspartate transaminase. Differential action of thiol reagents with the supernatant enzyme.
    Stankewicz MJ; Cheng S; Martinez-Carrion M
    Biochemistry; 1971 Jul; 10(15):2877-84. PubMed ID: 5114530
    [No Abstract]   [Full Text] [Related]  

  • 6. Probing the active sites of aspartate: 2-oxoglutarate aminotransferases from Trichomonas vaginalis and pig heart cytoplasm using substrate analogues.
    Lowe PN; Rowe AF
    Comp Biochem Physiol B; 1987; 88(1):223-7. PubMed ID: 3500014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective modification of the mitochondrial isozyme of aspartate aminotransferase by -bromopropionate. II. Chemical structure of the modified site.
    Morino Y; Okamoto M
    Biochemistry; 1972 Aug; 11(17):3196-201. PubMed ID: 5048283
    [No Abstract]   [Full Text] [Related]  

  • 8. Inactivation of aspartate aminotransferase during transamination with chloropyruvate. Evidence against modification of Cys390 in cytosolic isoenzyme.
    Osman AM; Yamano T
    Biochem Biophys Res Commun; 1976 May; 70(1):153-9. PubMed ID: 1275934
    [No Abstract]   [Full Text] [Related]  

  • 9. Action of gostatin and beta-methylene-DL-aspartate (BMA) on cerebellar aspartate aminotransferase (AAT) histochemical reaction.
    Arenas Díaz G; Martínez-Rodriguez R
    Cell Mol Biol; 1987; 33(4):477-82. PubMed ID: 3664557
    [No Abstract]   [Full Text] [Related]  

  • 10. Kinetics of the proteolysis of aspartate aminotransferase in various states of the active site.
    Makarov AA; Ivanov VI; Vol'kenshtein MV
    Mol Biol; 1974 Nov; 8(3):347-54. PubMed ID: 4474586
    [No Abstract]   [Full Text] [Related]  

  • 11. Acylation of aspartate aminotransferase.
    Turano C; Giartosio A; Riva F; Baroncelli V
    Biochem J; 1967 Sep; 104(3):970-7. PubMed ID: 6049935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemical relaxation spectrum of glutamic aspartic aminotransferase/erythro-beta-hydroxyaspartate.
    Czerlinski GH; Malkewitz J
    Biochemistry; 1965 Jun; 4(6):1127-37. PubMed ID: 5839999
    [No Abstract]   [Full Text] [Related]  

  • 13. A kinetic investigation of the interaction of erythro-beta-hydroxyaspartic acid with aspartate aminotransferase.
    Hammes GG; Haslam JL
    Biochemistry; 1969 Apr; 8(4):1591-8. PubMed ID: 5805298
    [No Abstract]   [Full Text] [Related]  

  • 14. An L-aspartate: 2-oxoglutarate aminotransferase reference material from human erythrocytes: preparation and characterization.
    Rej R; Vanderlinde RE; Fasce CF
    Clin Chem; 1972 Apr; 18(4):374-83. PubMed ID: 5012261
    [No Abstract]   [Full Text] [Related]  

  • 15. Redesign of the substrate specificity of Escherichia coli aspartate aminotransferase to that of Escherichia coli tyrosine aminotransferase by homology modeling and site-directed mutagenesis.
    Onuffer JJ; Kirsch JF
    Protein Sci; 1995 Sep; 4(9):1750-7. PubMed ID: 8528073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crystal structures of true enzymatic reaction intermediates: aspartate and glutamate ketimines in aspartate aminotransferase.
    Malashkevich VN; Toney MD; Jansonius JN
    Biochemistry; 1993 Dec; 32(49):13451-62. PubMed ID: 7903048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Citrulline accumulation in mice induced by administration of L-hydrazinosuccinate.
    Yamada RH; Wakabayashi Y; Iwashima A; Hasegawa T
    Biochem Pharmacol; 1988 Sep; 37(18):3435-9. PubMed ID: 3421994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo inhibition of aspartate aminotransferase in mice by L-hydrazinosuccinate.
    Yamada R; Wakabayashi Y; Iwashima A; Hasegawa T
    Biochim Biophys Acta; 1987 Feb; 911(3):372-5. PubMed ID: 3814611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [B6 enzymes. II. Affinity labeling of aspartate aminotransferase and the structure of its active site].
    Morino Y
    Seikagaku; 1973 Dec; 45(12):993-1014. PubMed ID: 4799691
    [No Abstract]   [Full Text] [Related]  

  • 20. [Selective inhibition of aspartate transaminase by analogues of glutamic acid].
    Khomutov RM; Kovaleva GK; Severin ES; Vdovina LV
    Biokhimiia; 1967; 32(5):900-7. PubMed ID: 5599897
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.